Get Diamond plan for FREE

    logo

    ETHZilla Corporation Warrant (ATNFW)

    Price:

    0.43 USD

    ( - -0.03 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    ATNFW
    Name
    ETHZilla Corporation Warrant
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare
    Price
    0.430
    Market Cap
    2.599M
    Enterprise value
    -2.765M
    Currency
    USD
    Ceo
    Lloyd Blair Jordan
    Full Time Employees
    4
    Website
    180lifesciences.com
    Ipo Date
    2017-06-27
    City
    Palo Alto
    Address
    Building 4

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Walgreens Boots Alliance, Inc.

    VALUE SCORE:

    0

    Symbol
    WBA
    Market Cap
    10.369B
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare

    2nd position

    Insmed Incorporated

    VALUE SCORE:

    7

    Symbol
    INSM
    Market Cap
    31.695B
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare

    The best

    BeOne Medicines Ltd.

    VALUE SCORE:

    9

    Symbol
    ONC
    Market Cap
    37.639B
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.208
    P/S
    14.652
    P/B
    0.105
    Debt/Equity
    1.116
    EV/FCF
    -26.004
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    122.543
    Earnings yield
    -4.809
    Debt/assets
    0.492
    FUNDAMENTALS
    Net debt/ebidta
    -1.935
    Interest coverage
    -675.781
    Research And Developement To Revenue
    0.202
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.000
    Capex to revenue
    0.000
    Capex to depreciation
    -0.001
    Return on tangible assets
    -0.223
    Debt to market cap
    8.249
    Piotroski Score
    2.000
    FUNDAMENTALS
    PEG
    0.036
    P/CF
    -2.507
    P/FCF
    -3.225
    RoA %
    -22.303
    RoIC %
    -23.658
    Gross Profit Margin %
    100.000
    Quick Ratio
    10.073
    Current Ratio
    10.073
    Net Profit Margin %
    -5.477k
    Net-Net
    -41.140
    FUNDAMENTALS PER SHARE
    FCF per share
    -1.560
    Revenue per share
    0.331
    Net income per share
    -18.128
    Operating cash flow per share
    -1.560
    Free cash flow per share
    -1.560
    Cash per share
    4.293
    Book value per share
    35.847
    Tangible book value per share
    35.847
    Shareholders equity per share
    35.847
    Interest debt per share
    40.031
    TECHNICAL
    52 weeks high
    0.443
    52 weeks low
    0.360
    Current trading session High
    0.443
    Current trading session Low
    0.360
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    -3.56%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.276
    logo
    Country
    FR
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.555

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.167

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.088
    logo
    Country
    CA
    Sector
    Healthcare
    Industry
    Medical - Pharmaceuticals
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.050

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.106

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.049

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.040

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.115
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.022

    No data to display

    DESCRIPTION

    180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.

    NEWS